Determination of lornoxicam in human plasma by LC/MS/MS

Yaoxue Xuebao

Volumn 39, Issue 2, 2004, Pages 132-135

  Zeng, Ya Lin ^a   Chen, Xiao Yan ^a   Zhang, Yi Fan ^a   Zhong, Da Fang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Liquid chromatograpy tandem mass spectrometry; Lornoxicam; Pharmacokinetics; Plasma drug concentration

Indexed keywords

FORMIC ACID; LORNOXICAM; METHANOL; PIROXICAM; WATER; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALYTICAL EQUIPMENT; AREA UNDER THE CURVE; ARTICLE; ATMOSPHERIC PRESSURE; CHINESE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; ION MONITORING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; NORMAL HUMAN; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; PIROXICAM; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 3242769198     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Balfour JA, Fitton A, Barradell LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions [J]. Drugs, 1996, 51(4):639-657.
2. Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam [J]. Clin Pharmacokinet, 1998, 34 (6):421-428.
3. Suwa T, Urano H, Shinohara Y, et al. Simultaneous high-performance liquid chromatogric determination of lornoxicam and its 5′-hydroxy metabolite in human plasma using electrochemical detection [J]. J Chromatogr, 1993, 617 (1):105-110.
4. Radhofer-Welte S, Dittrich P. Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid [J]. J Chromatogr B, 1998, 707(1-2):151-159.
5. Zhong DF. Some aspects in establishing standard curves in bioanalyses with the weighted least squires method [J]. Chin J Pharm Anal, 1996, 16(5):343-346.
6. Shah VP, Midha KK, Hulse JD, et al. Bioanalytical methods validation - a revisit with a decade of progress [J]. Pharm Res, 2000, 17(12):1551-1557.
7. Bonnabry P, Leemann T, Dayer P. Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam [J]. Eur J Clin Pharmacol, 1996, 49(4):305-308.